Assessment of Cytokines, microRNA and patient related outcome measures in Conversion Disorder/Functional Neurological Disorder (CD/FND) : the CANDO clinical feasibility study

Van Der Feltz-Cornelis, Christina Maria orcid.org/0000-0001-6925-8956, Brabyn, Sally orcid.org/0000-0001-5381-003X, Ratcliff, Jonathan et al. (5 more authors) (2021) Assessment of Cytokines, microRNA and patient related outcome measures in Conversion Disorder/Functional Neurological Disorder (CD/FND) : the CANDO clinical feasibility study. Brain, Behavior, & Immunity - Health. 100228. ISSN 2666-3546

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2021 The Authors
Dates:
  • Accepted: 18 February 2021
  • Published (online): 24 February 2021
  • Published: 1 May 2021
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Hull York Medical School (York)
The University of York > Faculty of Sciences (York) > Health Sciences (York)
Depositing User: Pure (York)
Date Deposited: 03 Mar 2021 11:20
Last Modified: 18 Feb 2024 00:25
Published Version: https://doi.org/10.1016/j.bbih.2021.100228
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.bbih.2021.100228

Downloads

Filename: CANDO_manuscript_1802021accepted_version.docx

Description: CANDO manuscript 1802021accepted version

Licence: CC-BY-NC-ND 2.5

Filename: 1_s2.0_S2666354621000314_main.pdf

Description: Assessment of cytokines, microRNA and patient related outcome measuresin conversion disorder/functional neurological disorder (CD/FND): TheCANDO clinical feasibility study

Licence: CC-BY-NC-ND 2.5

Export

Statistics